Autolus Therapeutics Alternatives & Competitors
12 companies similar to Autolus Therapeutics — Focused on the development of precisely targeted, controlled & highly active T c...
Cullinan Therapeutics
Science That Moves
Cambridge, United States
Immunocore
Science to Transform Lives
Abingdon, United Kingdom
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
HotSpot Therapeutics, Inc.
Discovering new allosteric therapies with the ability to treat disease in new ways
Boston, United States
Track all Autolus Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Seismic Therapeutic
The Machine Learning Immunology Company
Watertown, United States
Io Therapeutics
Io therapeutics focuses on developing drugs that target nuclear receptors in order to trea...
Treeline
Making medicines at the highest level
Watertown, United States
Adendra Therapeutics
Translating dendritic cell biology into new therapies for cancer and autoimmunity.
London, United Kingdom
Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for canc...
Cambridge, United States
Asylia Therapeutics
Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...
Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
San Diego, United States
Gracell Biotechnologies
A Member of the AstraZeneca Group
Shanghai, China
About Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer
Development of autologous T cell therapies, Advanced cell programming, Manufacturing of T cells, Clinical trial management, Pipeline products for cancer and autoimmune diseases
Patients with cancer and autoimmune diseases, Healthcare professionals, Investors interested in biotech innovations, Research institutions
CAR T Cell Therapy, T Cell Programming, Cancer Treatment, Autologous T Cell Therapies, Next-generation Therapies, Obe-cel (obecabtagene Autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7, AUTO8, Autoimmune Disease Treatment, Biopharmaceuticals, Therapeutic Pipeline
B2B, B2D
Product Sales, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Autolus Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Autolus Therapeutics on 1 Apr 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.